Position in LLY
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$145,298,959
+$35,486,702 QoQ
Shares Held
121,140
+1.5% QoQ
Ownership
0.013%
of shares outstanding
% of Portfolio
0.26%
of 13F equity value
Holder Rank
#314
of 4,601 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 97%
Shared 0%
None 3%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026BROWN ADVISORY INC holds $966,440,001 across 15 Drug Manufacturers - General names. LLY ranks #4 (15.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
1,028,187 | $261,128,650 | |
| 2 | ABBV |
AbbVie Inc.
|
870,702 | $219,103,450 | |
| 3 | MRK |
Merck & Co., Inc.
|
1,365,877 | $175,515,193 | |
| 4 | LLY |
ELI LILLY & Co
This page
|
121,140 | $145,298,959 | |
| 5 | AMGN |
Amgen Inc
|
118,830 | $43,030,717 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
252,085 | $31,848,418 | |
| 7 | NVS |
Novartis AG
|
186,086 | $29,163,396 | |
| 8 | SNY |
Sanofi
|
469,285 | $20,019,697 |
All Filings in LLY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $145,298,959 | 121,140 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $109,812,257 | 119,391 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $127,430,191 | 118,575 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $90,394,899 | 118,473 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $85,049,060 | 109,103 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $89,182,586 | 107,981 | Shares | Defined | 2025-04-30 | |
| 2024-12-31 | $82,492,832 | 106,856 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $96,532,906 | 108,961 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $100,268,117 | 110,747 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $86,614,953 | 111,336 | Shares | Defined | 2024-04-24 | |
| 2023-12-31 | $68,378,263 | 117,303 | Shares | Defined | 2024-02-08 | |
| 2023-09-30 | $64,232,153 | 119,584 | Shares | Defined | 2023-10-25 | |
| 2023-06-30 | $56,348,414 | 120,151 | Shares | Defined | 2023-07-31 | |
| 2023-03-31 | $42,276,030 | 123,103 | Shares | Defined | 2023-05-08 | |
| 2022-12-31 | $42,888,519 | 117,233 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $38,413,332 | 118,798 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $31,315,104 | 96,583 | Shares | Defined | 2022-11-14 | |
| 2022-03-31 | $25,706,574 | 89,767 | Shares | Defined | 2022-11-14 | |
| 2021-12-31 | $24,881,344 | 90,078 | Shares | Defined | 2022-01-27 | |
| 2021-09-30 | $20,769,777 | 89,893 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $20,717,162 | 90,263 | Shares | Defined | 2021-07-29 | |
| 2021-03-31 | $17,362,862 | 92,939 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $16,855,126 | 99,829 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $14,712,002 | 99,392 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $15,957,473 | 97,195 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $13,355,683 | 96,278 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||